Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance

Go back to Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance
(NASDAQ: AZYO) Delayed: 1.49 --0 (-0%)
Previous Close $1.49    52 Week High $ 
Open $0.00    52 Week Low $ 
Day High $1.49    P/E N/A 
Day Low $1.49    EPS $ 
Volume 33,510       

(NASDAQ: ELUT) Delayed: 0.83 +0.01 (1.22%)
Previous Close $0.82    52 Week High $ 
Open $0.84    52 Week Low $ 
Day High $0.85    P/E N/A 
Day Low $0.76    EPS $ 
Volume 2,522